Product Information
SIROLIMUS 1 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.9516 per EA under NDC 68462068301. Its NADAC has been published 294 times since Nov 11, 2020.
Strength
1 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462068301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SIROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA208691On Market Since
10/16/2020
Pharmacological Classes
Price Statistics
The NADAC for SIROLIMUS 1 MG TABLET has been published 294 times since Nov 11, 2020, and over the history we have for it it has declined 86.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9516 per EA |
|---|---|
| All-time high | $7.3204 (Feb 10, 2021) |
| All-time low | $0.9516 (Jun 17, 2026) |
| 52-week high | $2.0873 |
| 52-week low | $0.9516 |
| Median price | $2.8479 |
| Average price | $3.6430 |
| Largest weekly change | -38.5% (Nov 20, 2024) |
| Weeks tracked | 294 |
| Tracking since | Nov 11, 2020 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SIROLIMUS 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIROLIMUS 1 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.9516 per EA (NDC 68462068301), effective Jun 24, 2026.
How has the price of SIROLIMUS 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIROLIMUS 1 MG TABLET has declined 86.3%. It has been tracked across 294 weekly CMS publications since Nov 11, 2020.
What are the highest and lowest recorded NADAC prices for SIROLIMUS 1 MG TABLET?
Since Nov 11, 2020, the NADAC for SIROLIMUS 1 MG TABLET has ranged from a low of $0.9516 (Jun 17, 2026) to a high of $7.3204 (Feb 10, 2021), with a median of $2.8479 per EA.
Are there cheaper alternatives to SIROLIMUS 1 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as SIROLIMUS 1 MG TABLET, but none are currently priced below it.
Who manufactures SIROLIMUS 1 MG TABLET?
SIROLIMUS 1 MG TABLET (NDC 68462068301) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification